Trials / Unknown
UnknownNCT01379742
Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy
Comparison of Health Related Quality of Life and Other Clinical Parameters Between ThinSeed™ and OncoSeed™ for Permanent Low Dose Rate Implantation in Localized Prostate Cancer
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Prostate Cancer Foundation of Chicago · Academic / Other
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate health related quality of life factors in patients undergoing low dose rate prostate brachytherapy. Patients will be randomized to Iodine-125 Thinstrand (for use with 20 g needles) or Rapidstrand (for use with standard 18 g needles). Urinary, bowel, sexual function and bother will be measured by the EPIC questionnaire at various time intervals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RapidStrand seeds for use with 18g needle | Rapidstrand seeds are standard size and are used with 20 g needles |
| DEVICE | ThinStrand | ThinStrand seeds are smaller in diameter and used with 20g needles |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2013-02-01
- First posted
- 2011-06-23
- Last updated
- 2013-02-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01379742. Inclusion in this directory is not an endorsement.